Canada’s Peptide Intelligence Source

The peptide industry,
uncensored.

What Health Canada won’t say. What your supplier won’t admit. What the research actually shows. Delivered weekly to Canadians who need to know.

Get the Weekly Briefing →

Read Latest →

48+
Compounds Covered

12K+
Readers

Weekly
Updates

100%
Independent

What We Cover

⚖ Regulations & Law

What Health Canada is watching, changing, and cracking down on. The rules that govern what you can buy, import, and use — explained in plain English.

Read More →

🚨 Scam Watch

Fake products, underdosed peptides, fabricated COAs, and dangerous suppliers. We name what the industry won’t — so you can protect yourself.

Read More →

📈 Industry Trends

What’s entering research, what’s gaining traction, and what’s quietly fading. The compounds, the conversations, and where the science is heading.

Read More →

Latest Updates

The Weekly Peptide Briefing

What’s changing in regulations. Which vendors are getting flagged. What research dropped this week. Delivered to Canadians first — no hype, no BS.

Peptide Confidential provides independent news and educational content only. Nothing here constitutes medical, legal, or regulatory advice. Always consult a qualified healthcare provider. | Disclaimer · Privacy Policy · Terms of Use
Services
About
Reviews
Why Us
Contact

Regulations & Law

What Health Canada is watching, changing, and enforcing. In plain English.

Regulations & Law

BPC-157 in Canada: What Health Canada’s Position Actually Means

Leave a Comment / Regulations & Law / peptideconf

BPC-157 sits in a legal grey zone in Canada. Here’s what Health Canada’s position actually means — and what it doesn’t.